References
- FosterPJBuhrmannRQuigleyHAJohnsonGJThe definition and classification of glaucoma in prevalence surveysBr J Opthalmol2002862238242
- AsraniSZeimerRWilenskyJGieserDVitaleSLindenmuthKLarge diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucomaJ Glaucoma20009213414210782622
- CoakesRLBrubakerRFThe mechanism of timolol in lowering intraocular pressure in the normal eyeArch Ophthalmol1978961120452048363105
- SaxenaRPrakashJGuptaSKMathurPPharmacotherapy of glaucomaIndian J Pharmacol20023427185
- GaasterlandDKupferCRossKStudies of aqueous humor dynamics in man, IV: effects of pilocarpine upon measurements in young normal volunteersInvest Ophthalmol197514118488531184317
- LippaEACarlsonLEEhingerBDose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitorArch Ophthalmol199211044954591562255
- WakiMYoshidaYOkaTAzumaMReduction of intraocular pressure by topical administration of an inhibitor of the Rho-associated protein kinaseCurr Eye Res200122647047411584347
- TokushigeHInataniMNemotoSEffects of topical administration of y-39983, a selective rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeysInvest Ophthalmol Vis Sci20074873216322217591891
- TaniharaHInataniMHonjoMTokushigeHAzumaJAraieMIntraocular pressure-lowering effects and safety of topical administration of a selective ROCK inhibitor, SNJ-1656, in healthy volunteersArch Ophthalmol2008126630931518332309
- TaniharaHInoueTYamamotoTK-115 Clinical Study GroupPhase 2 randomized clinical study of a Rho kinase inhibitor, K-115, in primary open-angle glaucoma and ocular hypertensionAm J Ophthalmol2013156473173623831221
- OrihashiMShimaYTsunekiHKimuraIPotent reduction of intraocular pressure by nipradilol plus latanoprost in ocular hypertensive rabbitsBiol Pharm Bull2005281656815635165
- ImpagnatielloFBorghiVGaleDCA dual acting compound with latanoprost amide and nitric oxide releasing properties, shows ocular hypotensive effects in rabbits and dogsExp Eye Res201193324324921356209
- Nakamura-ShibasakiMLatiefMAKoJAFunaishiKKiuchiYEffects of topical adrenergic agents on prostaglandin E2-induced aqueous flare and intraocular pressure elevation in pigmented rabbitsJpn J Ophthalmol20166029510226832333
- BraslowRAGregoryDSAdrenergic decentralization modifies the circadian rhythm of intraocular pressureInvest Ophthalmol Vis Sci19872810173017323654147
- HonjoMTaniharaHInataniMEffects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facilityInvest Ophthalmol Vis Sci200142113714411133858
- Van de VeldeSVan BergenTSijnaveDAMA0076, a novel, locally acting Rho kinase inhibitor, potently lowers intraocular pressure in New Zealand white rabbits with minimal hyperemiaInvest Ophthalmol Vis Sci20145521006101624474276
- FukunagaTIkesugiKNishioMThe effect of the Rho-associated protein kinase inhibitor, HA-1077, in the rabbit ocular hypertension model induced by water loadingCurr Eye Res2009341424719172469
- NishioMFukunagaTSugimotoMThe effect of the H-1152P, a potent Rho-associated coiled coil-formed protein kinase inhibitor, in rabbit normal and ocular hypertensive eyesCurr Eye Res200934428228619373576
- WilliamsRDNovackGDvan HaarlemTKopczynskiCAR-12286 Phase 2A Study GroupOcular hypotensive effect of the Rho kinase inhibitor AR-12286 in patients with glaucoma and ocular hypertensionAm J Ophthalmol2011152583484121794845
- PercicotCLSchnellCRDebonCHaritonCContinuous intraocular pressure measurement by telemetry in alpha-chymotrypsin-induced glaucoma model in the rabbit: effects of timolol, dorzolamide, and epinephrineJ Pharmacol Toxicol Methods19963642232289040114
- VareillesPSilverstoneDPlazonnetBLe DouarecJCSearsMLStoneCAComparison of the effects of timolol and other adrenergic agents on intraocular pressure in the rabbitInvest Ophthalmol Vis Sci1977161198799621145
- BartelsSPRothHOJumblattMMNeufeldAHPharmacological effects of topical timolol in the rabbit eyeInvest Ophthalmol Vis Sci19801910118911976106643
- SugrueMFMallorgaPSchwamHBaldwinJJPonticelloGSA comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animalsCurr Eye Res1990966076152117519
- NagataAMishimaHKKiuchiYHirotaAKurokawaTIshibashiSBinding of antiglaucomatous drugs to synthetic melanin and their hypotensive effects on pigmented and nonpigmented rabbit eyesJpn J Ophthalmol199337132388100592
- DinslageSMcLarenJBrubakerRIntraocular pressure in rabbits by telemetry II: effects of animal handling and drugsInvest Ophthalmol Vis Sci19983912248524899804159
- TakenakaJMochizukiHKuniharaETanakaJKiuchiYEvaluation of rebound tonometer for measuring intraocular pressure at deviated angle and positionCurr Eye Res201136542242821501075
- TaniharaHInoueTYamamotoTK-115 Clinical StudyAdditive intraocular pressure-lowering effects of the Rho kinase inhibitor ripasudil (K-115) combined with timolol or latanoprost: a report of 2 randomized clinical trialsJAMA Ophthalmol2015133775576125880207
- YamagishiRHonjoMAoyamaYUchidaTAiharaMAltered interactions of concomitant administrations of ROCK inhibitor and para sympathetic agonist in mouse IOP and outflow dynamicsInvest Ophthalmol Vis Sci2016 E-abstract 3011
- GuptaSKAgarwalRGalpalliNDSrivastavaSAgrawalSSSaxenaRComparative efficacy of pilocarpine, timolol and latano-prost in experimental models of glaucomaMethods Find Exp Clin Pharmacol2007291066567118200329